SCHEMBL26847280

SCHEMBL26847280

CC(=O)c1cccc(CNc2nc(-c3cccs3)c(C#N)c(=O)[nH]2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 10/20 0.59
PRNP P04156 5/20 0.54
RXFP1 Q9HBX9 5/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
NPSR1 Q6W5P4 4/20 0.54
MAPT P10636 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP2C19 P33261 2/20 0.49
PSMD14 O00487 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
BRD4 O60885 1/20 0.48
SERPINH1 P50454 1/20 0.47
THRB P10828 1/20 0.47
APEX1 P27695 1/20 0.47
MC4R P32245 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087965 0.92 ACMSD (0.70) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL26847283 0.87 PRNP (0.53) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL24087878 0.86 ACMSD (0.70) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL24088170 0.83 ACMSD (0.55) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL26847147 0.83 ACMSD (0.85) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL24087912 0.79 ACMSD (0.48) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL26847281 0.79 ACMSD (0.47) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL24087921 0.79 ACMSD (0.54) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL26847267 0.79 ACMSD (0.52) ACMSDPRNPRXFP1MEN1KMT2A
SCHEMBL26847495 0.78 ACMSD (0.56) ACMSDPRNPRXFP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885PRNP 569/4885RXFP1 4311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.